Vosevi® (28 tabs) is a brand name prescription medication approved by the US FDA & EMA for the treatment of chronic Hepatitis C across all genotypes in adults with or without liver cirrhosis (compensated) who failed previous treatments with certain advanced Hep C regimens. Treatment recommendations for Vosevi® are different depending on viral genotype and prior treatment history.
- Vosevi® overall established cure rate across all 6 strains of Hepatitis C is about 97%
- Vosevi® side effects profile is quite mild especially with enough water intake
- Consult a doctor before concurrent administration of other drugs and supplements
- Vosevi® is contraindicated in patients taking the drug Rifampin
Active Ingredients : Sofosbuvir 400 mg / Velpatasvir 100 mg / Voxilaprevir 100 mg
Produced by Gilead Sciences Inc. of the USA